Data Sheet 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.pdf ‌ Santenna Chenchula (14775163)

“…Overall, 7.5% of patients carried CYP2D6 variants and 20.6% carried CYP2C19 variants, for which CPIC guidelines recommend alternative drug selection or dose modification.</p>Discussion<p>This study demonstrates a high prevalence of actionable CYP2D6 and CYP2C19 variants in the Central Indian population, underscoring the need for pharmacogenetic integration in psychiatric prescribing in Indian clinical settings, to enhance treatment efficacy and minimize adverse events.…”

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif ‌ Jichang Liu (1263291)

“…Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.…”

Survey of dysphagia protocol use (Carnaby et al., 2025) ‌ Giselle D. Carnaby (22575401)

“…Using bolus/texture modification guidelines (i.e., International Dysphagia Diet Standardization Initiative Framework) is uncommon.…”

تعديلات قانون العقوبات الأردني: نظرة تحليليّة ونقديّة ‌ Al-Zoubi , Muath Yahia

Ստացեք ամբողջական տեքստը

أثر فيروس كورونا في اختلال التوازن العقدي وطرائق معالجته في عقد الإجارة: دراسة فقهية قانونية (الأردن أنموذجًا)... ‌ Damour, Iyad Falah

Ստացեք ամբողջական տեքստը

المنهج القرآني في التزكية: آيات حد الزنا أنموذجًا ‌ Hamdan, Sawsan Arafat Musa

Ստացեք ամբողջական տեքստը

Figure 1 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma ‌ Marianna Carrabotta (8193039)

“…CDS displayed a signature enriched for genes involved in embryonic stem cell development (Benporath_ES_1), <i>KRAS</i> signaling (Sweet_KRAS_TARGETS_DN), <i>WT1</i> target genes (Kim_WT1_TARGETS_UP), and chromatin modification (Mikkelsen_NPC_HCP_WITH_H3K27ME3). The enrichment score curve was obtained using GSEA software. …”